Immunostimulation: Does it work in COPD?

Chest

Volumn 126, Issue 5, 2004, Pages 1406-1408

  Jindal, Surinder K ^a,b  

^a Postgrad Inst Med Educ and Res ^*

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BACTERIUM LYSATE; CORTICOSTEROID; IMMUNOSTIMULATING AGENT; LW 50020; MUCOLYTIC AGENT; SL 04; UNCLASSIFIED DRUG;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG USE; EDITORIAL; HOSPITALIZATION; HUMAN; IMMUNOSTIMULATION; INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

EID: 8744258856     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.5.1406     Document Type: Editorial

References (20)

1. Collet JP, Shapiro P, Ernst P, et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease: the PARI-IS Study Steering Committee and Research Group; Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med 1997; 156:1719-1724
2. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
3. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(suppl 5):SI-S28
4. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 pt 2):S77-S121
5. Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322:1271-1274
6. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management and prevention of COLD. NHLMI/WHO Workshop Report. Bethesda, MD: National Heart, Lung and Blood Institute. NIH Publication No. 2001; 2701:1-100
7. Guidelines for management of chronic obstructive pulmonary disease (COPD) in India: a guide for physicians (2003). Ind J Chest. Dis Allied Sci 2004; 46:137-153
8. Ahrens J, Wiedenbach M. Efficacy of the immunostimulant Broncho-Vaxom [in German]. Schweiz Med Wochenschr 1984; 114:932-934
9. Keller R. Multicenter double blind trial of Broncho-Vaxom in chronic bronchitis. Schweiz Med Wschr 1984; 114:934-937
10. Debbas N, Derenne JP. Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly. Lung 1990; 168(Suppl):737-740
11. Xinogalos S, Duratsos D, Varonos D. Clinical effectiveness of broncho-vaxom (BV) in patients with chronic obstructive pulmonary disease. Int J Immunother 1993; 9:135-142
12. Mauel J. Stimulation of immunoprotective mechanisms by OM-85 BV: a review of results from in vivo and in vitro studies. Respiration 1994; 61(Suppl 1):8-15
13. Cvoriscec B, Ustar M, Pardon R, et al. Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study. Respiration 1989; 55:129-135
14. Djuric O, Mihailovic-Vucinic V, Stojcic V. Effect of bronchovaxom on clinical and immunological parameters in patients with chronic obstructive bronchitis: a double-blind, placebo-controlled study. Int J Immunother 1989; 5:139-143
15. Germouty J. Immunotherapy of recurrent respiratory infections: double-blind study of a new immunomodulator in 60 patients [in French]. Rev Pneumol Clin 1986; 42:207-213
16. Orcel B, delclaux B, Baud M, et al. Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients: preliminary results at six months in 291 patients [in French]. Rev Mal Respir 1993; 10:23-28
17. Grove AK, Bergemann R, Keller R. Preventive treatment of chronic bronchitis: a cost-effectiveness analysis for an immunoactive bacterial extract in Switzerland. BMJ Economics 1996; 10:1-14
18. Schaad UB, Mütterlein R, Goffin H. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double blind placebo controlled multicenter study. Chest 2002; 122:2042-2049
19. Carmona-Ramirez MA, Alvarez-Gomez V, Berber A. Use of OM-85 BV for the prevention of acute respiratory tract infections in occupational medicine. J Int Med Res 2002; 30:325-329
20. Anthonisen NR. OM-85 BV for COPD. Am J Respir Crit Care Med 1997; 156:1713-1714